Overview
Sari Jacoby is a Hematologist and an Oncologist in Newark, New Jersey. Dr. Jacoby is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Sickle Cell Disease, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 Lyons Ave, D2, Newark, NJ 07112
Msk Nassau
Raphael Steiner is an Oncologist in Uniondale, New York. Dr. Steiner is rated as an Elite provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Steiner is currently accepting new patients.
Barnabas Health Medical Group PC
Israel Grossman is a Hematologist Oncology specialist and a Hematologist in Livingston, New Jersey. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.
David Straus is a Hematologist in New York, New York. Dr. Straus is rated as an Elite provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hodgkin LymphomaDr. Jacoby isDistinguished. Learn about Hodgkin Lymphoma.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Sickle Cell DiseaseDr. Jacoby isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- Classical Hodgkin LymphomaDr. Jacoby isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Colorectal CancerDr. Jacoby isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Jacoby isAdvanced. Learn about Familial Colorectal Cancer.
- Hemoglobin C DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin E Disease.
- Hemoglobin SC DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin SC Disease.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jacoby isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Jacoby isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Jacoby isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Jacoby isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.